Thursday, February 23, 2017
   
Text Size

About Institute of Human Virology Nigeria (IHVN)


Bookmark and Share

The Institute of Human Virology, Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine, Baltimore in the United States of America. It has grown to become a leading local non-governmental organization addressing the HIV/AIDS crises in Nigeria through the development of infrastructure for treatment, care, prevention, and support for people living with and those affected by HIV/AIDS but has now expanded its services to other infectious and non-infectious diseases including, cancer, tuberculosis, malaria and other diseases. IHVN is structured to develop and maintain linkages with local and international organizations in collaborative ways that support the Government of Nigeria's health sector strategic plans. IHVN key technical and funding partners are the Centers for Disease Control and Prevention (CDC) and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The Institute now offers Anti-retroviral Treatment (ART) services in 316 facilities, PMTCT services in 593 facilities, tuberculosis services in 161 facilities and HIV Counseling and Testing Services in 601 facilities under its ACTIONPlusUp project. Also, through funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria, DR-TB, 16 treatment centers offer treatment for drug resistant tuberculosis, 46 ART services, 164 PMTCT facilities and 1,785 facilities, malaria services. All these facilities and treatment centers comprise of primary, secondary and tertiary health centers in twenty states. Fourteen of the hospitals it supports are University Teaching Hospitals. IHVN, which has expanded activities to meet the growing public health challenges in Nigeria, has grown into an organization of about 491 staff members, from initial staff strength of ten.

HIV Services

The HIV program of the Institute focuses on anti-retroviral treatment for adult and children (including pregnant women), laboratory diagnosis and tracking of patient's status, care and support, prevention of mother-to-child transmission of HIV services, HIV counseling and testing, support to orphans and vulnerable children, training and research. The table below show achievements made in this area

CUMMULATIVE ACHIEVEMENTS IN HIV/AIDS/TB FROM INCEPTION TO SEPTEMBER 2016

 

ACTIONPlusUp

Global Fund

         Total

Individuals counseled, tested and received results

5,977,499

1,164,822

7,142,321

Pregnant women counseled, tested and received results

2,416,539

649,203

3,065,742

Pregnant women confirmed positive

78,636

10,264

88,900

Pregnant women provided ARV prophylaxis 68,644 8,056 76,700

Clients cumulatively enrolled in the HIV Care program

360,368

75,422

435,790

Clients cumulatively initiated on ART

244,772

45,839

290,611

Paediatric clients cumulatively initiated (Subset of ART above)

15,430

2,577

18,007

Clients provided TB treatment

41,825

1,392

43,217

The Institute provides these services in Nasarawa, Kano, Katsina, Delta, Ondo, Ogun, Osun, Benue, Nasarawa and Ekiti states including the Federal Capital Territory. All these have been achieved through funding from the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention, the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Tuberculosis/Drug Resistant TB Intervention

In the 161 sites that IHVN supports, over 43,000 people living with HIV have been provided with TB treatment.

With funding from the Global Fund to Fight AIDs, Tuberculosis and Malaria, the Institute has tested 125,179 people and given treatment to 2,463 people who have drug-resistant tuberculosis. 1,523 service providers also received training on DR-TB management from inception till March 2016.

The Institute has built a Bio-Safety Level 3 laboratory in the National TB Leprosy Training Center in Zaria, Nigeria, one of the first of its kind in Africa. With this, multi-drug resistant tuberculosis and other illnesses are being diagnosed in the country

Malaria Program

The Institute is supporting the use of insecticide-treated nets and Artemisin in Combination therapy for malaria prevention and treatment in Kogi, Jigawa, Katsina and Benue States. This has been done with funding from Global Fund to Fight AIDS, Tuberculosis and Malaria through the National Malaria Elimination Program

The Institute has distributed Long Lasting Insecticide Treated nets to over 5 million people, 8.9 million people have received artemisin in combination therapy treatment for malaria in the 1,785 facilities being supported by the Institute.

Cancer Registration/Research

IHVN in collaboration with the Nigerian Federal Ministry of Health (FMOH) and the International Agency for Research on Cancer (IARC) has organized trainings in cancer registration for 25 institutions in Nigeria.The Institute has taken a lead in coordinating cancer registration in Nigeria. It currently hosts the National System of Cancer Registries (NSCR). NSCR was conceived in 2009, as a collaborative effort between IHVN, Federal Ministry of Health (FMOH), and cancer registries of federal health institutions in Nigeria. The main objective of this program is to provide data from Nigerian cancer registries on the most common cancers, cancer incidence and cancer mortality statistics. For more information, click here

The Institute is also participating in a multi-institutional research funded by the National Institutes of Health to develop a better understanding of cervical cancer and the processes involved in the development of the disease. To this end, free cervical cancer screening is being offered in seven hospitals in the country. These hospitals are, Asokoro District Hospital, National Hospital Abuja, Garki Hospital Abuja, Federal Medical Center Keffi, Kubwa General Hospital, Wuse General Hospital and University of Abuja Teaching Hospital. Cervical cancer screening is done at these sites using HPV/DNA testing which is the most sensitive method for screening. For more information, click here

Training Activities

The Institute has trained health care workers to on ante-retroviral treatment, strategic information, care and support, prevention, laboratory services and equipment maintenance, blood safety, HIV counselling and testing, pharmocovigilance, and malaria and cancer prevention, management and control.  31,178 people have been trained to provide quality services. IHVN also has accreditation to offer Continuing Professional Development Program for medical doctors to acquire credits for the annual renewal of their license. Our training centers and halls are also equipped to handle training sessions. For more information, click here

Research

IHVN conducts biomedical research focusing on HIV/AIDS, tuberculosis, cancer and other non-communicable diseases. The Institute has also been a contributor to scientific literature by publishing in several international peer review journals. For more information on the major research projects the Institute is implementing, click here

Funding

The activities of the Institute are funded by international organizations which include:

  • Centers for Disease Control and Prevention (CDC)
  • The Global Fund to fight AIDS, Tuberculosis and Malaria (GF)
  • University of Maryland, Baltimore USA (UMB)
  • United States' National Institute for Health (NIH)
  • International Development Research Center (IDRC)
  • World Health Organization

Locally, IHVN is a sub-recipient to the National Agency for the Control of AIDS (NACA) and also the National Malaria Elimination Program under the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF).

 

:: Privacy Policy

IHVN frowns at reproduction of the content of this website without prior permission.This act is illegal and punishable under the law.

:: Support and Funding

The Institute of Human Virology, Nigeria AITRP Training Programmes are supported and funded by the Fogarty International Center.
FacebookTwitterGoogleYoutube

IHVN Member's Logon